Drugs / JPB898
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06587451 | Dec 2024 → Jan 2026 | melanoma | Sandoz | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JPB898 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06587451 ↗ |
| Route | Intravenous | “Induction and Maintenance: Intravenous (IV)” NCT06587451 ↗ |